Abdominal Solid Organ Transplantation in the Obese Patient

Erin C. Hall, Dorry L. Segev

Research output: Chapter in Book/Report/Conference proceedingChapter


The prevalence of obesity is increasing in patients with end-stage kidney and liver disease. Transplantation is the treatment of choice for obese patients who meet candidate screening criteria. Evidence-based candidate evaluation procedures should be in place to identify appropriate obese transplantation candidates most likely to derive benefit from transplantation. On the waitlist, obese patients are less likely to receive transplantation. After transplantation, the complications associated with obese transplant recipients are not drastically different from those of any other obese surgical patient; the real difference is seen in the choice and monitoring of immunosuppression regimens. Questions remain about "nonideal" obese patients with more than one perioperative risk factor and what the potential survival benefit and outcomes after transplantation might be for these patients.

Original languageEnglish (US)
Title of host publicationCritical Care Management of the Obese Patient
Number of pages10
ISBN (Print)9780470655900
StatePublished - Apr 19 2012
Externally publishedYes


  • Immunosuppression regimen
  • Metabolic syndrome
  • Obesity
  • Perioperative risk
  • Transplantation outcomes
  • Waitlist disparities

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Abdominal Solid Organ Transplantation in the Obese Patient'. Together they form a unique fingerprint.

Cite this